These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23549561)
1. More patients get good diabetes control, but only a minority meet all goals. Mitka M JAMA; 2013 Apr; 309(13):1335-6. PubMed ID: 23549561 [No Abstract] [Full Text] [Related]
2. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II). Boytsov S; Logunova N; Khomitskaya Y; Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151 [TBL] [Abstract][Full Text] [Related]
3. Poor control and management of cardiovascular risk factors among Albanian diabetic adult patients. Toti F; Bejtja G; Hoti K; Shota E; Agaçi F Prim Care Diabetes; 2007 Jun; 1(2):81-6. PubMed ID: 18632024 [TBL] [Abstract][Full Text] [Related]
4. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954 [TBL] [Abstract][Full Text] [Related]
5. Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence. Davidson MH J Clin Lipidol; 2010; 4(1):72-3; discussion 74. PubMed ID: 21122630 [No Abstract] [Full Text] [Related]
6. Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidence. Gosmanov AR J Clin Lipidol; 2010; 4(1):69-71; discussion 74. PubMed ID: 21122629 [No Abstract] [Full Text] [Related]
7. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Malik S; Lopez V; Chen R; Wu W; Wong ND Diabetes Res Clin Pract; 2007 Jul; 77(1):126-33. PubMed ID: 17118478 [TBL] [Abstract][Full Text] [Related]
8. Multifactorial intervention and mortality in type 2 diabetes. Tayek JA N Engl J Med; 2008 May; 358(21):2292; author reply 2292-3. PubMed ID: 18504827 [No Abstract] [Full Text] [Related]
9. Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative. Chalasani S; Peiris DP; Usherwood T; Redfern J; Neal BC; Sullivan DR; Colagiuri S; Zwar NA; Li Q; Patel A Med J Aust; 2017 Jun; 206(10):436-441. PubMed ID: 28566070 [TBL] [Abstract][Full Text] [Related]
10. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Wallgren S; Berry-Cabán CS; Bowers L Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249 [TBL] [Abstract][Full Text] [Related]
11. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)]. Sato A Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426 [TBL] [Abstract][Full Text] [Related]
12. Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges. Gavin JR; Stolar MW; Freeman JS; Spellman CW J Am Osteopath Assoc; 2010 May; 110(5 Suppl 6):S2-14; quiz S15-6. PubMed ID: 20554501 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in diabetes: a story of missed opportunities? Fagot-Campagna A; Gary TL; Benjamin SM Diabetes Care; 2001 Nov; 24(11):2015-6. PubMed ID: 11679489 [No Abstract] [Full Text] [Related]
14. Treatment of glycemic control in diabetes in the CVOT era. Einhorn D J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129 [No Abstract] [Full Text] [Related]
15. An overlooked condition. For diabetics, the hospital can be a dangerous place. Nicholas L Mod Healthc; 2005 Nov; 35(46):24. PubMed ID: 16334819 [No Abstract] [Full Text] [Related]
16. Diabetes basics. Navigating your way to optimal health. Hieronymus L; Hood G Diabetes Self Manag; 2006; 23(5):76-8, 80-4. PubMed ID: 17022131 [No Abstract] [Full Text] [Related]
17. Bile acid sequestrants and diabetes: introduction and overview to the supplement. Jialal I Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1(Suppl 1):S1-2. PubMed ID: 20973745 [TBL] [Abstract][Full Text] [Related]
18. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. McFarlane SI; Jacober SJ; Winer N; Kaur J; Castro JP; Wui MA; Gliwa A; Von Gizycki H; Sowers JR Diabetes Care; 2002 Apr; 25(4):718-23. PubMed ID: 11919131 [TBL] [Abstract][Full Text] [Related]
19. Medication adherence and glycemic control among diabetes patients in developing countries. Basu S J Health Popul Nutr; 2019 Nov; 38(1):32. PubMed ID: 31718711 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study. Wang R; Fratiglioni L; Liang Y; Welmer AK; Xu W; Mangialasche F; Johnell K; Qiu C PLoS One; 2015; 10(3):e0119582. PubMed ID: 25799502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]